Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Fall;11(Suppl 1):S14-8.

Side Effects of alpha-Blocker Use: Retrograde Ejaculation

Steven A Kaplan  1
Affiliations

Side Effects of alpha-Blocker Use: Retrograde Ejaculation

Steven A Kaplan. Rev Urol. 2009 Fall.

Abstract

There are currently 5 alpha-blockers that are approved by the US Food and Drug Administration to treat lower urinary tract symptoms (LUTS). The American Urological Association guidelines committee believes that all alpha-blockers are equally effective. However, alpha-blockers differ in their likelihood of causing abnormal ejaculation. This article discusses the effects on ejaculatory function, and specifically retrograde ejaculation, of the currently available alpha-blockers being used to treat men with LUTS due to benign prostatic hyperplasia.

Keywords: Benign prostatic hyperplasia; Lower urinary tract symptoms; Retrograde ejaculation; α-Blockade.

PubMed Disclaimer

References

    1. Lepor H, Gup DI, Baumann M, Shapiro E. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia. Urology. 1988;32:21–26. - PubMed
    1. Narayan P, Tewari A. Overview of alpha-blocker therapy for benign prostatic hyperplasia. Urology. 1998;51(suppl 1):38–45. - PubMed
    1. American Urological Association Education and Research, authors. Results of the Treatment Outcomes Analyses. 2006. [Accessed November 10, 2009]. pp. 1–142. (Guideline on the Management of Benign Prostatic Hyperplasia (BPH)). http://www.auanet.org/content/guidelines-and-quality-care/clinicalguidel....
    1. Gillenwater JY, Conn RL, Chrysant SG, et al. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study. J Urol. 1995;154:110–115. - PubMed
    1. Andersson KE, Gratzke C. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol. 2007;4:368–378. - PubMed